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 2 
SUMMARY 22 
Empty virus-like particles (eVLPs) of Cowpea mosaic virus (CPMV) are currently being utilized 23 
as reagents in various biomedical and nanotechnology applications. Here, we report the crystal 24 
structure of CPMV eVLPs determined using X-ray crystallography at 2.3 Å resolution and 25 
compare it with previously reported cryo-electron microscopy (cryo-EM) of eVLPs and virion 26 
crystal structures. Although the X-ray and cryo-EM structures of eVLPs are mostly similar, there 27 
exist significant differences at the C-terminus of the small (S) subunit. The intact C-terminus of 28 
the S subunit plays a critical role in enabling the efficient assembly of CPMV virions and eVLPs, 29 
but undergoes proteolysis after particle formation. In addition, we report the results of mass 30 
spectrometry-based proteomics analysis of coat protein subunits from CPMV eVLPs and virions 31 
that identify the C-termini of S subunits undergo proteolytic cleavages at multiple sites instead of 32 
a single cleavage site as previously observed. 33 
 34 
Keywords: Cowpea mosaic virus, CPMV, eVLPs, Structure, Mass spectrometry, Proteomics 35 
 36 
Highlights: 37 
 38 
The crystal structure of eVLPs is extremely similar to that of CPMV virions. 39 
 40 
After assembly, the surface exposed C-termini of S subunits undergo proteolysis at multiple 41 
sites. 42 
 43 
Presence of different ratios of processed S subunits results in slow and fast electrophoretic 44 
forms of CPMV.  45 
  46 
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 3 
INTRODUCTION 47 
Cowpea mosaic virus (CPMV), the type member of the Comoviridae subfamily of the 48 
plant-infecting Secoviridae, consists of single-stranded, positive-sense, bipartite RNA genome of 49 
RNA-1 (6kb) and RNA-2 (3.5kb). The two RNAs are encapsidated into separate particles and 50 
both RNAs required for virus infection. The virus particles are ~310 Å in diameter and display 51 
pseudo T=3 icosahedral symmetry (Fig. 1A, B). Each particle consists of 60 copies of a protomer 52 
comprising a large (L) and a small (S) coat protein (CP) subunits derived from a single CP 53 
precursor (VP60) encoded by the RNA-2 and processed by the RNA-1 encoded 24K proteinase. 54 
The L subunit (41kDa) is composed of WZRMHOO\UROOȕ-barrel domains, and the S subunit (23kDa) 55 
consists of a single jellyroll ȕ-barrel (Fig. 1C).  56 
 57 
Due to simplicity and robustness of its capsid and the availability of an atomic resolution 58 
structure (Lin et al., 1999; Stauffacher et al., 1987), CPMV has been widely used in bio-59 
nanotechnology applications. These include the display of antigenic peptides on the particle 60 
surface (Dalsgaard et al., 1997; Porta et al., 1994; Usha et al., 1993), the chemical coupling of a 61 
variety of moieties (Aljabali et al., 2010; Aljabali et al., 2012; Steinmetz et al., 2006a, b) and the 62 
deposition of minerals on the particle surface (Aljabali et al., 2011; Shah et al., 2009; Steinmetz 63 
et al., 2009) as well as development of particles to deliver drugs coupled to their outer surface to 64 
cells (Aljabali et al., 2013). A particular advantage of CPMV for in vivo applications is that 65 
particles are well tolerated in mammals (Destito et al., 2009; Rae et al., 2005). However, a 66 
disadvantage of using CPMV particles produced via infection is that approximately 90% of such 67 
particles contain one or other genomic RNAs. As a result preparations of such particles retain 68 
their infectivity to plants, with attendant bio-containment concerns, and the particles cannot be 69 
efficiently loaded with cargo. To address these issue a system for the production of RNA-free 70 
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 4 
empty virus-like particles (eVLPs) has been developed. These can be generated by co-expression 71 
of the coat protein precursor VP60 along with the 24K viral proteinase in Nicotiana benthamiana 72 
(Montague et al., 2011; Saunders et al., 2009).  CPMV eVLPs generated this way have already 73 
proven useful as reagents for bio- and nanotechnology applications (Lebedev et al., 2016; 74 
Sainsbury et al., 2011; Sainsbury et al., 2014; Wen et al., 2012).  75 
 76 
To gain insight into the structural similarities between eVLPs and native CPMV virions, 77 
we have conducted structural studies on CPMV eVLPs using X-ray crystallography. 78 
Furthermore, this allows comparison with the recently determined cryo-EM structure of eVLPs 79 
at 3.0 Å, performed independently (Hesketh et al., 2015), and facilitates the correlation of eVLP 80 
structures determined using two different methods. Hence, here we report the crystal structure of 81 
eVLPs at 2.3 Å resolution and compare it with the cryo-EM structure of eVLPs (Hesketh et al., 82 
2015) and the crystal structure of CPMV virion (PDB-ID: 1NY7) (Lin et al., 1999; Stauffacher et 83 
al., 1987). In addition, we have carried out mass spectrometry-based proteomics analysis on the 84 
S subunits from CPMV eVLPs and virions to investigate in detail the location of the proteolytic 85 
cleavage sites of the S subunit that result in the occurrence of the slow and fast electrophoretic 86 
forms of the virus (Niblett and Semancik, 1969). Each protomer of CPMV that contains 587 87 
amino acid (a.a.) residues undergoes proteolytic processing at residues Gln374-Gly375 by the 88 
viral protease prior or during assembly generating the large (L) and small (S) subunits (Franssen 89 
et al., 1982). The full-length L and S subunits contain 374 and 213 a.a respectively. It has been 90 
shown that the intact C-terminus of the S subunit is required for the efficient assembly of both 91 
CPMV virions and eVLPs (Sainsbury et al., 2011; Taylor et al., 1999). After particle assembly, 92 
the surface exposed C-terminus is proteolysed up to residue Leu563 (189) (Taylor et al., 1999). 93 
In the virion crystal structure (PDB-ID: 1NY7), the last visible C-terminal residue of the S-94 
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 5 
subunit, Leu 563 (189) is partially exposed (Lin et al., 1999) (we have chosen to use the 95 
continuous numbering system for the S subunit to be consistent with the sequence databases, 96 
instead of the old numbering that is shown in parenthesis and starts from the residue number 1, 97 
which was used in the description of the virion structure (Lin et al., 1999)). However the rate of 98 
loss of the C-terminal amino acids appears to be slower with eVLPs than with virus (Sainsbury et 99 
al., 2011), raising the possibility that some of residues may be visible in the X-ray structure of 100 
eVLPs. 101 
The results presented in this manuscript demonstrate that the overall structure of eVLPs 102 
is extremely similar to that of virions produced via infection, whose crystal structure was 103 
determined previously (Lin et al., 1999). Furthermore, with the exception of the C-terminus of S 104 
subunit, the crystal structure of eVLPs reported in the current study shows close agreement with 105 
the independently obtained cryo-EM structure (Hesketh et al, 2015). The proteomics analysis of 106 
eVLPs and of virions has revealed that the C-terminus of the S subunit of CPMV undergoes 107 
proteolytic processing at multiple sites suggesting the possibility that CPMV eVLPs and virions 108 
are composed of S subunits of variable lengths. This is in agreement with previous observations 109 
that the presence of different proportions of processed and unprocessed C-termini of S subunits 110 
are likely to result in fast and slow electrophoretic forms of CPMV virions (Niblett and 111 
Semancik, 1969). 112 
 113 
RESULTS 114 
Crystal Structure Determination of eVLPs 115 
Crystals of CPMV eVLPs were grown under the following conditions: 0.1 M Sodium 116 
acetate pH 4.68, 3-4%(w/v) PEG3350, 0.3 M Ammonium sulfate and 5% (v/v) glycerol, at 20°C.  117 
The crystals belong to space group I41, D cE cF cĮ ȕ 118 
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 6 
Ȗ with two particles in the crystallographic asymmetric unit. The eVLP crystals are 119 
distinct from the crystals of CPMV virions (of space group I23), grown under different 120 
conditions 0.05M potassium phosphate pH 7.0, 0.4M Ammonium sulfate, 2%(w/v) PEG8000 121 
(Lin et al., 1999). The statistics associated with diffraction data and model refinement are shown 122 
in Table 1. Binwise statistics for various resolution bins are provided in the Table S1. The details 123 
of data collection, data processing, structure determination and model refinement are described 124 
in the experimental procedures section. Briefly, the structure was determined using molecular 125 
replacement method using the program Phaser (McCoy et al., 2007) and refined using the 126 
program CNS (Brunger et al., 1998). The R-factor of the eVLP structure is relatively high 127 
(Rwork: 0.357; Rfree: 0.359), but is consistent with the molecular replacement R-factor (0.351) 128 
calculated between the Fobs and the Fcalcs derived from back-transformed electron density 129 
obtained by imposing 120-fold non-crystallographic symmetry (NCS). The high model R-factor 130 
is likely due to imposition of 120-fold strict NCS constraints, in a high-symmetry space group 131 
(I41), resulting from 2 particles present in the crystallographic asymmetric unit of a high 132 
symmetry space group (I41). Further discussion on this topic can be found in the methods 133 
section.  134 
 135 
A majority of the crystal structure of CPMV eVLP was built in strong electron density at 136 
a contour level of 1.0V (Fig. 2A) with the exception of the last two residues (566-567) at the C-137 
terminus of S subunit. The contour level was reduced to 0.5V in the omit maps to model the 138 
residues, 566-567 (Fig. 2B, C). However, all the reported residues, 1-369 (L subunit) and 375-139 
567 (S subunit) are clearly visible in the final refined maps (Fig. 2B).  The C-terminal residues 140 
370-374 of the L subunit and the residues 568-587 (194-213) of the S subunit are disordered in 141 
the crystal structure. It is possible that some of the latter unidentified residues of the S subunit 142 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 7 
could have been proteolytically removed prior to crystallization and hence likely to be absent in 143 
the crystals of eVLPs. 144 
 145 
CPMV eVLP Structure and Particle Organization 146 
The overall structure, size and organization of CPMV eVLPs is similar to that of the 147 
CPMV virion structure (Lin et al., 1999). The CPMV protomer contains 587 a.a. residues and 60 148 
copies of the protomer form an icosahedral particle with T=1 symmetry and an averaged 149 
diameter of ~310 Å. However, the same (T=1) icosahedral architecture can be described as 150 
displaying pseudo T=3 (pT=3) icosahedral symmetry, as tKH WKUHH ȕ-barrel domains of the 151 
protomer occupy comparable positions seen in a T=3 quasi-equivalent surface lattice (Fig. 1A, 152 
B). Each protomer undergoes proteolytic processing at residues Gln374-Gly375 by the 24K viral 153 
protease prior or during assembly generating the large (L) and small (S) subunits (Fig. 1C). In 154 
the eVLP structure, the L subunit (41kDa) is composed of ordered residues 1-369 that form two 155 
MHOO\UROOȕ-barrel domains, while the S subunit (23kDa) consisting of ordered residues 375-567 156 
(1-193) forms DVLQJOHȕ-barrel domain. The ȕ-barrel (ȕ3) of the small subunit is located near the 157 
five-fold axis, with the ȕ-barrels (ȕ1 and ȕ2) of the large subunit surrounding the three-fold axis 158 
(Fig. 1A, B).  159 
 160 
Comparison of CPMV eVLP and Virion Structures 161 
The crystal and cryo-EM structures of eVLP show a high degree of similarity with each 162 
another and also with the CPMV virion crystal structure. The structures have an overall root-163 
mean-square deviation (rmsd) of 0.518 Å between eVLP-X-ray and eVLP-EM; 0.527 Å between 164 
eVLP-X-ray and CPMV-virion (X-ray); and 0.445 Å between eVLP-EM and CPMV-virion (X-165 
ray) for 550 aligned CD atoms (Fig. 3A). The structure superpositions and calculation of rmsd 166 
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 8 
values were carried out using the UCSF Chimera program (Pettersen et al., 2004) and the 167 
graphics program O (Jones et al., 1991). Figure 4A-F show the rmsd values for the large and 168 
small subunits between the crystal and cryo-EM structures. Other than at the C-terminus of the S 169 
subunit, minor differences are observed at the residue Lys 176 of the large subunit and Asp 418 170 
(44) of the small subunit between the eVLP and virion structures due to differences in rotamer 171 
and alternate backbone conformations, respectively (Fig. 4G, H). However, the similar side 172 
chain conformation seen for the residue Lys 176 in both the eVLP structures compared to the 173 
virion structure (Fig. 4G) and its location on the capsid interior, near the icosahedral 2-fold axis, 174 
suggests that it might potentially interact with genomic RNA in CPMV virions. Other small 175 
structural differences with rmsds in the range of 1-2Å occur due to small changes in the residue 176 
locations (Fig. S2). Notwithstanding these differences, the eVLP and virion structures of CPMV 177 
appear to be very similar. We also compared the average B-factors per residue of eVLP and 178 
virion structures. Even though, the magnitudes of B-factors differ between the two capsids, the 179 
variation of B-factors along the polypeptide chain is very similar between the two structures 180 
(Fig. S3). This suggests that there are no significant differences between in the dynamics of 181 
eVLPs and virions, influenced by the absence or presence of genomic RNA, respectively. 182 
 183 
The major difference between the X-ray and cryo-EM structures of eVLPs is seen at the 184 
C-terminus of the S subunit. A helical segment of residues 564-576 (190-202) is ordered only in 185 
the eVLP cryo-EM structure, with preceding residues 558-563 (184-189) and succeeding 186 
residues 577-587 (203-213) that could not be modeled due to weak or disordered density (Fig. 187 
3B) (Hesketh et al., 2015). In contrast, the C-termini of the S subunit are continuously ordered 188 
until residues Arg567 (193) and Leu563 (189) in the crystal structures of eVLPs and CPMV 189 
virion, respectively (Fig. 3B) and in spite of different conditions used to grow crystals of eVLPs 190 
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 9 
(pH 4.7) and virions (pH 7.0). Of note, the cryo-EM structure of eVLPs was determined at pH 191 
7.0 (Hesketh et al., 2015). Furthermore, the coiled-structure formed by the visible C-terminal 192 
residues 557-567 of the S subunit, in the eVLP crystal structure, is consistent with secondary 193 
structure predictions (Buchan et al., 2013) (Fig. S1). Notably, the ordered helical segment of 194 
residues 568-576 (194-202) in the cryo-EM structure spatially superimposes onto residues 562-195 
567 (188-193) in the eVLP crystal structure (Fig. 3B). These structural differences seen at C-196 
terminus of the S subunit between the crystal and cryo-EM structures of the eVLPs may be 197 
attributable to different pHs 4.7 and 7.0 and/or different extents of proteolysis undergone by the 198 
eVLPs used in the respective studies. 199 
 200 
Mass Spectrometry and Proteomics 201 
The S subunit of CPMV eVLPs and virions is present in slow and fast electrophoretic 202 
forms. The slow form contains the full-length S subunits, while the fast form consists of 203 
proteolysed form(s) of S subunits. In freshly prepared samples of eVLPs and virions, which were 204 
dialyzed into 50mM Potassium Phosphate buffer (pH 7.0), both the slow and fast forms are 205 
present (Fig. 5A). However, within 2-3 weeks after purification of the eVLPs stored at 4°C, the 206 
S subunit contains mostly the fast (cleaved) form (Sainsbury et al., 2011). The extent of 207 
proteolysis is also found to be different based on the type of plant host used for the expression of 208 
CPMV or eVLPs, such as cowpea (Vigna unguiculata) compared with N. benthaminana (Fig. 209 
5B). Mass spectrometry and proteomics analysis of the electrophoretic slow and fast forms 210 
(bands) of the S subunit reveal that the slow (uncleaved) form contains the native C-terminus 211 
ending with the sequence Thr-Ala-Ala (Fig. 5C), while the fast form contains peptides with 212 
different C-termini ending with residue Leu563 (189), Leu564 (190) or Phe566 (192). The 213 
proteomics analysis on the fast form of S subunit of CPMV virions has identified the proteolysis 214 
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at Ph566 in addition to at Leu563 and Leu564 (Fig. 5C). It is important to emphasize that the 215 
slow electrophoretic band of the S subunit contains only the full length S subunit (213 a.a.), 216 
unlike the fast form that displays different C-termini and composed of a varying number of 217 
amino acids between 189-192. 218 
 219 
DISCUSSION 220 
CPMV particles are being used as reagents for various biomedical and nanotechnology 221 
applications. More recently, these applications have turned to using eVLPs rather than the 222 
infectious virus (Lebedev et al., 2016; Sainsbury et al., 2011; Sainsbury et al., 2014; Wen et al., 223 
2012). Therefore, it is of importance to structurally characterize eVLPs and analyze any 224 
significant differences that occur between the wild-type virus and eVLPs of CPMV. Previous 225 
studies have shown that the C-terminal 24-residues of the S subunit are important for particle 226 
assembly (Hesketh et al., 2015; Sainsbury et al., 2011), RNA encapsidation (Taylor et al., 1999) 227 
and the suppression of gene silencing (Canizares et al., 2004). Based on the location of the 228 
visible C-terminus (567) of the S subunit (Fig. 1B), the C-terminal 24-residues are likely to play 229 
crucial role in stabilizing the inter-protomer contacts around the 5-fold axis during assembly. 230 
These protomer-protomer associations lead to the formation of the pentamers of the protomers, 231 
and 12 such pentamers assemble together to form CPMV particles. Since, RNA encapsidation of 232 
CPMV likely to involve assembling of pentamers around the viral RNA, the C-terminal residues 233 
would also play an indirect role in RNA packaging. This assessment is in agreement with the 234 
assembly mechanism proposed by the cryo-EM studies (Hesketh et al., 2015). After assembly, 235 
the C-termini of S subunits of CPMV virions are prone to proteolysis and lose up to 24 residues 236 
without adversely affecting the particle integrity (Geelen et al., 1973; Niblett and Semancik, 237 
1970; Taylor et al., 1999). In freshly prepared samples, a significant proportion of the C-termini 238 
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of the S subunits are intact (Sainsbury et al., 2011), resulting in the occurrence of slow and fast 239 
electrophoretic forms of CPMV particles (Niblett and Semancik, 1969). However, most of the S 240 
subunits lose upto 24 a.a from their C-termini by about 2-3 weeks after the purification, when 241 
stored at 4°C (Sainsbury et al., 2011).  242 
 243 
The proteomics analysis on different electrophoretic forms (bands) of the S subunits of 244 
CPMV eVLPs as well as of virions suggests that the fast (cleaved) form of S subunits contain 245 
different or multiple C-terminal residues: Leu563 (189), Leu564 (190) and Phe566 (192), as 246 
opposed to a single cleavage site as previously reported (Taylor et al., 1999). The previous 247 
results were designed to ascertain the limit of cleavage and were obtained from a preparation of 248 
virions, produced in cowpea, which was deliberately aged for several weeks. Furthermore, the 249 
technique used, electrospray mass spectrometry of the entire S protein, did not permit the 250 
resolution of the results reported here. The observation that the fast form contains different C-251 
terminal residues implies that the CPMV eVLPs or virions might consist of the S subunits with 252 
their C-termini processed to varying lengths. However, the final cleavage site cannot be too far 253 
from Leu563 (189), otherwise the residues would be surface exposed and susceptible to further 254 
proteolysis. This is consistent with the observation that none of the peptides from fast form of the 255 
S subunit contain C-terminal residues beyond Phe566 (192) (Fig. 5C). 256 
 257 
The superposition of eVLP structures onto the virion structure of CPMV reveals a high 258 
degree of structural similarity with the exception of differences at the C-terminus of the S 259 
subunit (Fig. 3A). This shows that the CPMV eVLPs are able to assemble independently in the 260 
absence of nucleic acid and form capsids virtually identical to CPMV virion particles. The eVLP 261 
crystal structure shows continuous electron density until Arg567 (193), four residues beyond the 262 
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last cleavage seen at residue Leu563 (189) of the S subunit, identified by the proteomics analysis 263 
(Fig. 5C). A bifurcated salt-bridge is observed in the eVLP crystal structure between residue 264 
Glu559 (185) at the C-terminus of the reference S subunit and the residues Arg469 (95) and 265 
Asp478 (104) of the S subunit of the 5-fold related (clockwise) protomer that stabilizes the 266 
pentameric interface. The identification of a few additional residues beyond the limit of the 267 
cleavage site found in virions indicates that the X-ray structure represents an average structure of 268 
eVLPs that are composed of cleaved, partially cleaved and possibly uncleaved forms of the S 269 
subunit. The remaining residues beyond Arg567 (193) are either proteolysed and totally absent 270 
from the crystals used for structure determination or if present are disordered in the crystal 271 
structure. In addition, the identification of peptide fragments with residues downstream of 272 
Leu563 (189) in the proteomics analysis (Fig. 5C) suggests that the proteolysis may be either 273 
sequential in nature or may occur at several different sites and independently on different S 274 
subunits, as there are 60 such sites per particle. It is likely that after particle assembly, the C-275 
termini of the small subunit are continually proteolysed by host proteases at various basic or 276 
aromatic residues until the last cleavable/accessible residue Leu564 (190) or a residue close to it 277 
is reached.  278 
 279 
In the cryo-EM structure of eVLPs, a helical segment of thirteen residues 564-576 (190-280 
202) of the S subunit is found to be ordered beyond the last proteolysed residue Leu563 (189) 281 
(Hesketh et al., 2015). However, some of the residues, Leu564 (190) - Arg569 (195), in this 282 
peptide segment that are known to undergo proteolysis, according to above proteomics results, 283 
are buried and inaccessible in the cryo-EM structure. Hence, if these terminal residues as seen in 284 
the cryo-EM structure were to become accessible and undergo proteolytic processing, it would 285 
require conformational reorganization of the C-terminus. Indirect evidence that such a 286 
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conformational change occurs on proteolysis is provided by the observation that deliberate 287 
digestion of eVLPs with chymotrypsin, which cuts after amino acids 565 (191), (567) 193 and 288 
569 (195) of the S protein, sites similar those identified in this study, , significantly enhances 289 
their permeability to ions compared to the untreated eVLPs (Sainsbury et al., 2011).    290 
 291 
The results presented in this manuscript demonstrate that the overall structure of eVLPs 292 
is extremely similar to that of virions produced via infection, whose crystal structure was 293 
determined previously (Lin et al., 1999). Furthermore, based on the residuewise B-factor 294 
comparisons along the polypeptide chain, the particle dynamics of CPMV virions and eVLPs 295 
appear to be similar irrespective of whether or not the genomic RNA is packaged (Fig. S3). With 296 
the exception of the C-terminus of S subunit, the crystal structure of eVLPs reported in this study 297 
shows close agreement with the independently obtained cryo-EM structure (Hesketh et al, 2015). 298 
Taken together, the information obtained from X-ray and cryo-EM structures along with the 299 
proteomics analysis of eVLPs has provided new insights into the structure and processing of the 300 
C-terminus of the S subunit of CPMV as well as particle assembly. Such knowledge is important 301 
for developing eVLPs for biotechnological applications as this region has been known to control 302 
assembly and accessibility (Sainsbury et al., 2011).    303 
 304 
 305 
EXPERIMENTAL PROCEDURES 306 
 307 
Expression, Purification and Crystallization of CPMV eVLPs  308 
CPMV eVLPs were expressed and purified as previously described (Sainsbury et al., 309 
2014). CPMV eVLPs, at a concentration of 6.0 mg/ml, were crystallized by hanging drop vapor 310 
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diffusion by mixing 2µl of eVLPs with 2µl of reservoir solution containing 3-4%(w/v) 311 
PEG3350, 0.3 M Ammonium sulfate, 5% (v/v) glycerol and 0.1 M Sodium acetate pH 4.68 and 312 
stored at room temperature (20°C). Diamond shaped crystals appeared within 1-2 days and grew 313 
to a maximum size of ~0.3mm in about 1-2 weeks. The crystals were sequentially transferred 314 
into a reservoir solution containing 10%, 15% and 20% (v/v) and flash cooled in liquid nitrogen 315 
prior to data collection. 316 
 317 
Data Collection, Structure Determination, Model Building, and Refinement 318 
The diffraction data from the CPMV-eVLP crystals were collected on a Pilatus detector 319 
at the beamline 23-ID-D, GMCA at APS, Chicago. The crystals diffracted better than 2.3 Å 320 
resolution. The data was processed using HKL2000 (Otwinowski and Minor, 1997). The final 321 
data scaling and merging of the unmerged data derived from SCALEPACK (HKL2000) was 322 
done using the SCALA program (Evans, 2006). All the reflections with partiality > 0.6 were 323 
included in the dataset. Details of the data statistics are shown in Table 1 and Table S1. The 324 
CPMV eVLP crystals belong to the space group I41 with unit cell dimensions a=b=655.97 Å, 325 
c=571.45 Å, Į=ȕ=Ȗ=90° and contain two virus particles in the crystallographic asymmetric unit 326 
(16 particles in the unit cell), resulting in 120-fold non-crystallographic symmetry (NCS). The 327 
CMPV eVLP structure was determined by the molecular replacement method employing the 328 
program Phaser (McCoy et al., 2007) and using the poly-alanine model derived from the CMPV 329 
structure (PDB-ID: 1NY7).  The details of the particle orientations and positions are given in 330 
Table 1. The latter polyalanine model was oriented and positioned according to the Phaser 331 
solution and rigid body refined using the program X-PLOR (Brunger, 1992). The Initial electron 332 
density was generated with the phases from the rigid body refined polyalanine model and 333 
improved by employing the phase refinement procedure with 120-fold NCS averaging using the 334 
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RAVE and CCP4 suite of programs (CCP4, 1994; Jones, 1992). This resulted in a readily 335 
interpretable map at 2.3 Å with a final R-factor of 0.351 and a correlation coefficient of 0.68, 336 
calculated between the Fobs and the Fcalcs derived from back-transformed electron density. An 337 
initial model of CPMV protomer that occupies the icosahedral asymmetric unit, was built 338 
automatically using BUCCANEER program (Cowtan, 2008). The final model was adjusted 339 
manually into the electron density map contoured at 1.0ı using the programs COOT (Emsley et 340 
al., 2010) and O (Jones et al., 1991). The structure was refined using the program CNS imposing 341 
(strict) 120-fold NCS constraints (Brunger et al., 1998). Water molecules were identified using 342 
the program WATPEAK (CCP4, 1994) based on the difference (Fo-Fc) densities and later 343 
manually verified and adjusted using the graphics program COOT (Emsley et al., 2010). In the 344 
end 58 water molecules were included in the eVLP structure. The final refinement statistics are 345 
shown in Table 1. Model quality was analyzed using PROCHECK (Laskowski et al., 1993) and 346 
Stride (Heinig and Frishman, 2004) was used for the assignment of secondary structures. 347 
 348 
The high model R-factor is likely due to imposition of 120-fold NCS constraints, 349 
resulting from 2 particles present in the crystallographic asymmetric unit of high symmetry space 350 
group (I41). To improve the R-factor, it may be necessary to release the strict NCS constraints 351 
and impose them as restraints at high resolutions (e.g, 2.3 Å), particularly when more than one 352 
particle is present in the crystallographic asymmetric unit. This phenomenon is even more 353 
pronounced in a high symmetry space group relative to low symmetry space group P1 as seen in 354 
few cases (Khayat et al., 2011; Tars et al., 2000a, b). Even though NCS restraints were used in 355 
the refinement of simple (T=1) viruses, where 60-fold NCS was present (Larson et al., 2014), it 356 
is difficult to implement the same with 120-fold NCS because of a greater number of chains 357 
(120x2 = 240) involved. In the end, this may not significantly improve the model except for 358 
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slightly better statistics (i.e., R-factor), as the model R-factor (0.359) is very similar to molecular 359 
replacement R-factor (0.351) calculated between the Fobs and the Fcalcs derived from back-360 
transformed electron density obtained by imposing 120-fold NCS.  We tested if the imposition of 361 
120-fold NCS constraints is the reason for high R-factor at 2.3Å, by calculating the R-factors at 362 
different high-resolution limits of the data. The R-factors calculated at various high-resolution 363 
limits of 3 Å, 4 Å and 5 Å yielded increasingly lower R-factors: 0.325, 0.294 and 0.291, 364 
respectively. This indicates that the imposition of 120-fold strict NCS is likely the cause of 365 
relatively higher R-factors at 2.3 Å resolution. 366 
 367 
Mass Spectrometry and Proteomics 368 
The capsid protein subunits (L and S) of CPMV virus particles from Cowpea and CPMV 369 
eVLPs were separated on a SDS PAGE gel as previously described (Sainsbury et al., 2011).  The 370 
S subunit of CPMV virions and that of eVLPs contained two bands corresponding to the slow 371 
and fast forms (Fig. 5A,B). The bands corresponding to the slow and fast forms of the S subunit 372 
of eVLPs and of the fast form (only) of the virions were excised and submitted for proteomics 373 
mass spectrometry analysis by digestion with GluC protease. The excised gel bands were 374 
destained with a mixture of a 50:50 (v/v) dilution of acetonitrile-25 mM ammonium bicarbonate 375 
DQGGULHGZLWKD6SHHG9DFV\VWHP7KHSURWHLQVDPSOHVLQWKHJHOZHUHWKHQUHGXFHGLQȝORI376 
10 mM d,l-GLWKLRWKUHLWRO 6LJPD IRU  K DQG DON\ODWHG ZLWK  ȝO RI  P0 LRGRDFHWDPLGH377 
(Sigma) for 30 min in the dark prior to an 18-h GluC digestion at 37°C using a 1:30 (w/w) 378 
enzyme-to-substrate ratio. The resulting peptides were extracted twice with a 50:45:5 (v/v) 379 
volume of acetonitrile-water-IRUPLF DFLG DQG FRQFHQWUDWHG WR  ȝO EHIRUH EHLQJ DQDO\]HG 380 
Peptides were analyzed by reverse-phase chromatography prior to mass spectrometry analysis 381 
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and MS/MS samples were analyzed by using Mascot (version 2.1.04; Matrix Science, London, 382 
United Kingdom) as described in Powers et al (Powers et al., 2011). 383 
 384 
ACCESSION NUMBERS 385 
The coordinates and structure factor amplitudes of the eVLP crystal structure have been 386 
deposited in the PDB with the accession code 5fmo. 387 
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Table 1. Data collection and Refinement Statistics 402 
X-ray Source 23-ID-D, GMCA, APS 
Wavelength (Å) 0.858 
Space Group I41 
Cell parameters D cE cF cĮ ȕ Ȗ  
Number of particles 16/unit cell; 2/crystal asymmetric unit;  
VM (Å3/Da) 2.75 
Percent Solvent (%) 55 
Resolution (Å) 50-2.3 (2.42 ± 2.3)§ 
No. of unique reflections 3,192,399 (383,718) § 
Completeness (%) 60.3 (49.6) § 
Rmergea (%) 0.29 (0.452)
 §
 
I/ı 3.7 (1.7) § 
Particle orientations  
(Phaser solution) 
Particle-1: EULER 39.90, 71.85, 333.96 FRAC 0.252, 0.00, 0.0000 
Particle-2: EULER 74.83, 89.08, 189.73 FRAC 0.500, 0.249, 0.253 
Ordered residues 1-369 (L); 375-567 (S) 
Waters 58 
Refinement Statistics  
Resolution (Å) 20-2.3 
No. of reflections  1,861,715 
Degrees of NCS 120 
Rworkb   0.357 
Rfreec   0.359 
RMS bond length (Å) 0.009 
RMS bond angle (°) 1.527 
  
Ramachandran Plot Statistics  
Most Favorable (%) 78.2 
Allowed (%) 2.6 
Disallowed (%) 0 
aRmerge  >hi|Ih ± Ihi_hiIhi] where Ih is the mean of Ihi observations of reflection h. Numbers in 403 
§Shown in parenthesis are the statistics for the highest resolution shell. 404 
bRwork and cRfree  __)obs| - |Fcalc___)obs| x 100 for 95% of recorded data (bRwork) or 5% data (cRfree)   405 
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FIGURE LEGENDS 406 
Figure 1. Structure and organization of CPMV eVLPs. A) An icosahedral (pseudo) T=3 cage 407 
showing the geometric organization of the large (L)  and small (S) subunits in a CPMV capsid, 408 
shown in green and blue, respectively. The two E-barrels (E E of the L subunit encircle 409 
the 3-fold axis denoted by a yellow triangle. The E-barrel (E of the S subunit surround the 410 
icosahedral 5-fold vertices, identified by a yellow pentagon. The yellow diamond represents the 411 
location of icosahedral 2-fold axis. B) A surface representation of the subunit organization of the 412 
L and S subunits. The C-terminal residues (561-567) of the S subunit are shown in red colored 413 
surface. C) A ribbon diagram of the CPMV protomer depicting the secondary and tertiary 414 
structures of the L and S subunits. The N-termini of the L and S subunits are labeled as L-N and 415 
S-N, respectively and the visible C-termini are correspondingly labeled as L-C and S-C, 416 
respectively. Figures were generated using Chimera (Pettersen et al., 2004) and Pymol (The 417 
PyMOL Molecular Graphics System, Version 1.2r3pre, Schrödinger, LLC.) 418 
 419 
Figure 2. Representative electron density of the eVLP crystal structure. A) The (3Fo-2Fc) 420 
electron density illustrated by blue mesh at residue Tyr100 contoured at 1.0V. B) The continuous 421 
(3Fo-2Fc) density at the C-terminus of the S subunit comprising the terminal 16 residues (551-422 
567) in the crystal structure. C) An omit map showing the density at the C-terminus of the S 423 
subunit, calculated by omitting residues 554-567. The E ´-strand of residues 421-425, adjacent 424 
to the C-terminal residues is shown as reference. 425 
  426 
Figure 3. Superposition of CPMV protomers. A) A superposition of the eVLP-Xray (yellow), 427 
eVLP-cryoEM (blue) and native CPMV virion-X-ray (1NY7; green) structures. B) The close-up 428 
view of the superposition at the C-termini of the S subunits from three structures. Residues are 429 
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labeled in corresponding colors of the structures. A dashed line represents disordered residues, 430 
558-563 (184-189) in the eVLP-cryoEM structure. 431 
  432 
Figure 4. Graphs showing the root-mean-square deviation (rmsd) values between the crystal and 433 
cryoEM structures highlighting structural similarities and differences. Graphs: A, B and C show 434 
the rmsd values at each residue between the L subunits of the eVLP-Xray and CPMV (virion)-435 
Xray (1NY7) ; eVLP-Xray and eVLP-cryoEM; eVLP-cryoEM and CPMV-Xray (1NY7)  436 
structures, respectively. The CD atom deviations are shown by blue line and the average 437 
deviation of all atoms in each residue is indicated by red line. Graphs D, E and F show the rmsd 438 
values at each residue between the S subunits for the corresponding pairs as in graphs A, B and 439 
C, respectively. The residue numbers of S subunits, in graphs D, E and F, are shown from 1-193, 440 
which corresponds to residues 375-567. G) The side chain (rotamer) differences at residue Lys 441 
176 of the L subunit between the three structures: eVLP-Xray (yellow), eVLP-cryoEM (blue) 442 
and CPMV-Xray (1NY7; green). H) The conformational differences in the backbone of the 443 
structures at residue Asp418 (44) of the S subunit. 444 
 445 
Figure 5. SDS PAGE and proteomic analysis of CPMV eVLPs and virions. A) CPMV eVLPs, 446 
purified from N. benthamiana, Lane 1: molecular weight marker, Lane 2-CPMV eVLPs fresh 447 
prep, 3- CPMV eVLPs after storage at 4°C for more than 1 month (less slow forms of S subunit). 448 
The L subunit has a molecular weight of 41kDa and the S is subunit 23kDa. The lower case s and 449 
f letters (in gray) refer to slow (uncleaved) and fast (cleaved) bands of the S subunit. B) CPMV 450 
virion, Lane 1: molecular weight marker, Lane 2-4: samples purified from N. benthamiana and 451 
Lane 5-7: samples purified from cowpea plants. Different levels of proteolytic cleavage of S 452 
subunit are observed depending on the host plant. Samples from N. benthamiana look more 453 
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intact compared to samples from cowpea plants. The lower case s and f letters (in gray) refer to 454 
slow (uncleaved) and fast (cleaved) bands of the S subunit. C) List of identified peptides of the S 455 
subunit of CPMV virus and eVLPs after GluC protease digestion using proteomics mass 456 
spectrometry analysis. The cleavage point is indicated by a period (dot). The slow and fast forms 457 
of the S subunit were individually digested and the peptide sequences were identified. Selected 458 
amino acids are identified by their residue numbers. The sequence ending with TAA (587) 459 
corresponds to the native C-terminus of the full length of the S subunit (slow form). 460 
 461 
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Table 1. Data collection and Refinement Statistics 
X-ray Source 23-ID-D, GMCA, APS 
Wavelength (Å) 0.858 
Space Group I41 
Cell parameters D cE cF cĮ ȕ Ȗ  
Number of particles 16/unit cell; 2/crystal asymmetric unit;  
VM (Å3/Da) 2.75 
Percent Solvent (%) 55 
Resolution (Å) 50-2.3 (2.42 ± 2.3)§ 
No. of unique reflections 3,192,399 (383,718) § 
Completeness (%) 60.3 (49.6) § 
Rmergea (%) 0.29 (0.452)
 §
 
I/ı 3.7 (1.7) § 
Particle orientations  
(Phaser solution) 
Particle-1: EULER 39.90, 71.85, 333.96 FRAC 0.252, 0.00, 0.0000 
Particle-2: EULER 74.83, 89.08, 189.73 FRAC 0.500, 0.249, 0.253 
Ordered residues 1-369 (L); 375-567 (S) 
Waters 58 
Refinement Statistics  
Resolution (Å) 20-2.3 
No. of reflections  1,861,715 
Degrees of NCS 120 
Rworkb   0.357 
Rfreec   0.359 
RMS bond length (Å) 0.009 
RMS bond angle (°) 1.527 
  
Ramachandran Plot Statistics  
Most Favorable (%) 78.2 
Allowed (%) 2.6 
Disallowed (%) 0 
aRmerge  >hi|Ih ± Ihi_hiIhi] where Ih is the mean of Ihi observations of reflection h. Numbers in 
§Shown in parenthesis are the statistics for the highest resolution shell. 
bRwork and cRfree  __)obs| - |Fcalc___)obs| x 100 for 95% of recorded data (bRwork) or 5% data (cRfree)  
7DEOH
 1 
 
Supplemental Information 
 
Crystal structure and proteomics analysis of empty virus-like 
particles of Cowpea mosaic virus 
 
Nhung Huynh1, Emma L. Hesketh3, Pooja Saxena2§, Yulia Meshcheriakova2, You-Chan Ku1, 
Linh Hoang4, John E. Johnson1, Neil A. Ranson3, George P. Lomonossoff2 and Vijay S. Reddy1* 
 
1Integrative Structural and Computational Biology, 4Scripps Center for Metabolics and Mass 
Spectrometry, The Scripps Research Institute, La Jolla, CA, 92037, USA. 
2Dept. of Biological Chemistry, John Innes Centre, Norwich Research Park, Colney, Norwich 
NR4 7UH, UK. 
3Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, LS2 9JT, UK. 
 
 
* Corresponding author: Vijay S. Reddy; E-mail address: reddyv@scripps.edu 
 
 
§Present address: Department of Chemistry, Indiana University, 800 E. Kirkwood Ave., 
Bloomington, IN 47405-7102, USA. 
  
6XSSOHPHQWDO7H[W	)LJXUHV
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 2 
Table S1. Binwise data statistics of CPMV eVLP data set§. 
Dmax Dmin  Nmeas Nref % 
completeness Multiplicity <I/>/sd Rsym 
50.0 7.27 519449 123415 73.8 4.2 23.5 0.106 
7.27 5.14 800622 226437 74.0 3.5 8.4 0.258 
5.14 4.20 924694 292341 73.8 3.2 6.2 0.310 
4.20 3.64 767675 322157 68.7 2.4 3.2 0.358 
3.64 3.25 744592 338852 63.7 2.2 2.2 0.398 
3.25 2.97 708791 348780 59.3 2.0 1.9 0.415 
2.97 2.75 719693 365886 57.2 2.0 1.8 0.423 
2.75 2.57 796517 391997 57.0 2.0 1.8 0.431 
2.57 2.42 764142 398816 54.5 1.9 1.7 0.432 
2.42 2.30 681688 383718 49.6 1.8 1.7 0.452 
Totals  7427863 3192399 60.3 2.3 3.7 0.290 
§Scaling and merging was done using the SCALA program (Evans, 2006). 
Evans, P. (2006). Scaling and assessment of data quality. Acta Crystallogr D Biol Crystallogr 
62, 72-82. 
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Figure S1. Sequence based secondary structure prediction (SSP) of S subunit of CPMV. The C-terminal region 
displays mainly coil and beta-strand regions consistent with the X-ray structure of eVLPs. The old residue numbering 
is shown here. The residues 180-213 corresponds to residues  554-587 according to the new numbering.  The SSP was 
obtained using the PSIPRED server http://bioinf.cs.ucl.ac.uk/psipred/ (Buchan et al., 2013). 
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Figure S2. An example illustration of small structural variations with rmsds 1-2Å between different 
CPMV structures. Shown in atomic colors (yellow (C), red (O), blue (N)) is eVLP X-ray structure 
refined with CNS,  shown in cyan Is eVLP X-ray structure refined with X-PLOR, in magenta is eVLP 
cryo-EM structure and  the virion X-ray structure (PDB-ID: 1NY7) is show in green. 
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Figure S3. Plot comparing the average residue B-factors of the eVLP (blue line) and virion (red line)  X-
ray structures. Even though absolute values (magnitudes) differ between the two structures, the relative 
variations of the B-factors along the polypeptide chains appear to be similar.  
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